These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36650694)

  • 81. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The type 2 diabetes-specific dementia risk score (DSDRS) is associated with frailty, cognitive and functional status amongst Mexican community-dwelling older adults.
    Bello-Chavolla OY; Aguilar-Salinas CA; Avila-Funes JA
    BMC Geriatr; 2020 Sep; 20(1):363. PubMed ID: 32962659
    [TBL] [Abstract][Full Text] [Related]  

  • 83. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prevalence, overlap, and interrelationships of physical, cognitive, psychological, and social frailty among community-dwelling older people in Japan.
    Sugie M; Harada K; Nara M; Kugimiya Y; Takahashi T; Kitagou M; Kim H; Kyo S; Ito H
    Arch Gerontol Geriatr; 2022; 100():104659. PubMed ID: 35190333
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study.
    Rathmann W; Bongaerts B; Kostev K
    Diabetes Obes Metab; 2016 Aug; 18(8):840-3. PubMed ID: 27062643
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Management of type 2 diabetes mellitus in the elderly.
    Soe K; Sacerdote A; Karam J; Bahtiyar G
    Maturitas; 2011 Oct; 70(2):151-9. PubMed ID: 21890292
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.
    Tong L; Adler S
    Postgrad Med; 2018 May; 130(4):381-393. PubMed ID: 29667921
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of antidiabetic treatment on bone.
    Jackuliak P; Kužma M; Payer J
    Physiol Res; 2019 Nov; 68(Suppl 2):S107-S120. PubMed ID: 31842574
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty.
    Tamura Y; Omura T; Toyoshima K; Araki A
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33139628
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor versus insulin secretagogues.
    Gautier JF; Monguillon P; Verier-Mine O; Valensi P; Fiquet B; Dejager S; Charbonnel B
    Diabetes Res Clin Pract; 2016 Jun; 116():26-8. PubMed ID: 27321312
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Impact of frailty in older patients with diabetes mellitus: An overview.
    Cobo A; Vázquez LA; Reviriego J; Rodríguez-Mañas L
    Endocrinol Nutr; 2016; 63(6):291-303. PubMed ID: 26971016
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
    Freemantle N; Danchin N; Calvi-Gries F; Vincent M; Home PD
    Diabetes Obes Metab; 2016 Feb; 18(2):152-8. PubMed ID: 26511332
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Metabolic Characteristics of Frail Older People with Diabetes Mellitus-A Systematic Search for Phenotypes.
    Abdelhafiz AH; Keegan GL; Sinclair AJ
    Metabolites; 2023 May; 13(6):. PubMed ID: 37367862
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Impact of sex and glucose-lowering treatments on hypoglycaemic symptoms in people with type 2 diabetes and chronic kidney disease. The French Chronic Kidney Disease - Renal Epidemiology and Information Network (CKD-REIN) Study.
    Balkau B; Metzger M; Andreelli F; Frimat L; Speyer E; Combe C; Laville M; Jacquelinet C; Briançon S; Ayav C; Massy Z; Pisoni RL; Stengel B; Fouque D
    Diabetes Metab; 2019 Apr; 45(2):175-183. PubMed ID: 29706470
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Metabolic Impact of Frailty Changes Diabetes Trajectory.
    Sinclair AJ; Abdelhafiz AH
    Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837914
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effects of hypoglycaemic therapy on frailty: a multi-dimensional perspective.
    Abdelhafiz AH
    Expert Rev Endocrinol Metab; 2023 Jan; 18(1):53-65. PubMed ID: 36650694
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus-a choice determined by metabolic phenotype.
    Sinclair AJ; Pennells D; Abdelhafiz AH
    Aging Clin Exp Res; 2022 Sep; 34(9):1949-1967. PubMed ID: 35723859
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Triad of impairment in older people with diabetes-reciprocal relations and clinical implications.
    Abdelhafiz AH; Davies PC; Sinclair AJ
    Diabetes Res Clin Pract; 2020 Mar; 161():108065. PubMed ID: 32044347
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of glycemic control on frailty: a multidimensional perspective.
    Abdelhafiz AH
    Hosp Pract (1995); 2023 Aug; 51(3):124-134. PubMed ID: 37056204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.